Materials of PHC (Paris Hepatology Conference) 2017
- 08:30 - 08:40 Introduction - Patrick MARCELLIN (France)
-
08:40 - 10:00
HEPATITIS C - SESSION 1
Chairs :
Marc BOURLIERE (France) Rafael ESTEBAN (Spain)
-
08:40
Universal Hepatitis C treatment: strategies for simplification
- Tarik ASSELAH (France)
Download
-
08:55
Policies for HCV elimination
- Angelos HATZAKIS (Greece)
Download
- 09:10 Impact of therapy on the QOL - Geoffrey DUSHEIKO (UK)
- 09:45 Round table discussion
- 10:00 - 10:30 Coffee break
-
10:30 - 11:30
HEPATITIS C - SESSION 2
Chairs :
Nezam AFDHAL (USA) Antonio CRAXI (Italy)
-
10:45
Special populations
- Stefan ZEUZEM (Germany)
Download
-
11:00
Results in real life
- Robert FLISIAK (Poland)
Download
- 11:15 Round table discussion
- 11:30 - 11:50 CLINICAL CASE
-
11:30
Impact of therapy in a patient F1
- Eugene SCHIFF (USA)
Download
-
11:50 - 12:30
STATE OF THE ART LECTURE & AWARD
Chairman:
Patrick MARCELLIN (France)Download
-
11:50
From HCV to HBV cure
- Raymond SCHINAZI (USA)
Download
-
12:30 - 14:30 LUNCH WORKSHOPS 1-Future therapies for HBV and HDV: What can we expect?
Chair: Nezam AFDHAL (USA)
Download
2-How to optimize treatment in G3 patients
Chair: Graham FOSTER (UK)
3-DAAs treatment of patient with HIV-HCV co-infection
Chair: Stanislas POL (France)
Download
4-How to diagnose NASH?
Chair: Vlad RATZIU (France)
5-The microbiome in liver diseases: Where are we?
Chair: Arun SANYAL (USA)
Speaker:
Gabriel PERLEMUTER (France)
6-Treatment of HCC in real life
Chair: Massimo COLOMBO (Italy)
7-Optimisation de la prise en charge d’un patient avec ascite (French speaking lunch workshop)
Chairs: Georges-Philippe PAGEAUX (France) Christian TREPO (France)
-
14:30 - 15:30
NASH SESSION
Chairs :
Arun SANYAL (USA) Lawrence SERFATY (France)
-
14:30
Epidemiology of NASH
- Stefano BELLENTANI (Italy)
Download
-
14:45
Pathology of NASH
- Pierre BEDOSSA (France)
Download
- 15:00 Lifestyle intervention in NASH - Vlad RATZIU (France)
- 15:15 Therapies in NASH - Arun SANYAL (USA)
- 15:30 - 15:50 Coffee break
-
15:50 - 17:40 AROUND THE WORLD TABLE: ACCESS TO THERAPY Introduction
Chairman: Massimo COLOMBO (Italy)
WESTERN COUNTRIES
Chairman: Massimo COLOMBO (Italy)
Speakers: Maria BUTI (Spain)
Download
Antonio CRAXI (Italy)
Download
Graham FOSTER (UK)
Download
Michael FRIED (USA)
Download
Victor DE LEDINGHEN (France)
Download
Stefan ZEUZEM (Germany)
Download
OTHER COUNTRIES
Chairman: Michael FRIED (USA)
Speakers: Mustapha BENAZZOUZ (Morocco)
Download
Robert FLISIAK (Poland)
Download
Jinlin HOU (Chine)
Vasily ISAKOV (Russia)
Download
Raymundo PARANA (Brazil)
Adriana POPESCU (Romania)
Download
-
17:40 - 18:00
STATE OF THE ART LECTURE
Chairman:
Tarik ASSELAH (France)Download
- 17:40 The future of research on viral hepatitis - Charles RICE (USA)
-
18:00 - 18:10
Take home messages
-
Marc BOURLIERE (France)
Download
- 18:10 - 18:20 Conclusion - Patrick MARCELLIN (France)
- 19:30 Congress dinner
- 08:30 Introduction - Patrick MARCELLIN (France)
-
08:40 - 10:10
HEPATITIS B - SESSION 1
Chairs :
Jidong JIA (China) Georgios PAPATHEODORIDIS (Greece)
-
08:40
How to manage HBV patients in 2017?
- George LAU (Hong Kong)
Download
-
08:55
When can we stop NUCS in patients with chronic hepatitis B?
- Seng Gee LIM (Singapore)
Download
-
09:10
Long term impact of antiviral therapy (NUCs)
- Pietro LAMPERTICO (Italy)
Download
- 09:25 Round table discussion
- 10:00 - 10:30 Coffee break
-
10:30 - 11:30
HEPATITIS B - SESSION 2
Chairs :
Michael MANNS (Germany) Shiv SARIN (India)
-
10:30
New targets for HBV therapies
- Fabien ZOULIM (France)
Download
-
10:45
New anti-HBV strategies
- Edward GANE (New Zealand))
Download
-
11:00
How to improve access to therapy for HBV patients?
- Michael MANNS (Germany)
Download
- 11:15 Round table discussion
-
11:30 - 12:30
END-STAGE LIVER DISEASE
Chairs :
Richard MOREAU (France) Didier SAMUEL (France)
- 11:30 Prevention and treatment of variceal hemorrhage in 2017 - Jaime BOSCH (Spain & Switzerland)
-
11:45
Why and how to assess renal function in cirrhosis
- Paolo ANGELI (Italy)
Download
-
12:00
Management of cholestatic diseases in 2017
- Ulrich BEUERS (Netherlands)
Download
- 12:30 Round table discussion
-
12:45 - 14:30 LUNCH WORKSHOPS 8-Treatment of transplanted HCV patients: when and how?
Chair: Jordi BRUIX (Spain)
9-Need to assess HCV resistance to DAAs: is it useful and when?
Chair: Edward GANE (New Zealand))
10-Long term benefits and side effects of NUC therapy: where are we?
Chair: Georgios PAPATHEODORIDIS (Greece)
11-Optimal management of ascities
Chair: Peter FERENCI (Austria)
12-Management of autoimmune hepatitis
Chair: Michael MANNS (Germany)
13-How to manage patients with NASH?
Chair: Lawrence SERFATY (France)
14-Diagnostic et prise en charge d’un patient avec NASH (French speaking lunch workshop)
Chairs: Daniel DHUMEAUX (France) Jean-François David CADRANEL (France)
- 14:30 - 14:50 TWO PROGRAMS OF HCV ERADICATION - Graham FOSTER (UK)
-
Follow-up of the Georgian and Egyptian programs
Gamal ESMAT (Egypt)
Download
Tengiz TSERTSVADZE (Georgia)
Download
-
14:50 - 15:50
HCC SESSION
Chairs :
Jordi BRUIX (Spain) Massimo COLOMBO (Italy)
-
14:50
The molecular road map of HCC
- Jessica ZUCMAN ROSSI (France)
Download
- 15:05 The impact of anti HCV DAAs on HCC - Jordi BRUIX (Spain)
-
15:20
Reconsidering OLT to treat HCC in an era of donors shortage
- Didier SAMUEL (France)
Download
- 15:35 Round table discussion
-
15:50
Take home messages
-
Michael FRIED (USA)
Download
- 16:00 Conclusion - Patrick MARCELLIN (France)